Acceptance or refusal of the COVID-19 vaccine associated with routine vaccination
Article Sidebar
Main Article Content
Abstract
Introduction: One of the most effective measures for controlling the pandemic caused by the SARS-CoV-2 virus is the development and application of vaccines. However, despite their proven efficacy, these vaccines are rejected by the population. Several factors, including personal characteristics, can influence the level of acceptance.
Objective: Determine the association between routine vaccination and personal characteristics with the acceptance of the COVID-19 vaccine in Mexican adults.
Methods: This study employs a descriptive, correlational, and cross-sectional approach. The sample consisted of 554 adult residents of the state of Guanajuato, Mexico. The data was gathered via a 10-question online survey. The statistical analysis was conducted using descriptive statistics and the Chi-square test.
Results: The majority of participants had received the COVID-19 vaccine. Those who demonstrated greater acceptance of the vaccine were male participants, people aged 40 years or older, those with a university education, urban residents, and unemployed individuals. A significant association was found between the history of influenza vaccination and acceptance of the COVID-19 vaccine (X2= 19.24; p ≤ 0.001).
Discussion and Conclusion: As in other studies, participants demonstrated greater acceptance of the COVID-19 vaccine. Having been vaccinated against influenza influenced the decision to accept the COVID-19 vaccine. This result may be due to a recognized positive effect of vaccination.
Publication Facts
Reviewer profiles N/A
Author statements
- Editor & editorial board
- profiles
- Academic society
- N/A
- Publisher
- Universidad Nacional Autónoma de México
To learn about these publication facts, click 
PF is maintained by the Public Knowledge Project
Article Details
Dimensions citation
MÉTRICAS
References
(1) Ita K. Coronavirus disease (COVID-19): Current status and prospects for drug and vaccine development. Arch Med Res. 2021; 52(1): 15-24. https://doi.org/10.1016/j.arcmed.2020.09.010
(2) Secretaría de Salud. Vacúnate por ti, vacúnate por todos. México: SSA; s/f. https://bit.ly/4c1A2ER
(3) Organización Mundial de la Salud. Un total de 172 países y múltiples vacunas candidatas forman parte del Mecanismo de Acceso Mundial a las Vacunas contra la COVID 19. Ginebra: OMS; 2020. https://bit.ly/3R3kdoQ
(4) Administración de Alimentos y Medicamentos. Las vacunas contra el Covid-19 para el 2023-2024. EE.UU.: FDA; 2023. https://bit.ly/3wLqq27
(5) Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020; 382(21): 1969-73. https://doi.org/10.1056/NEJMp2005630
(6) Organización Panamericana de la Salud, Organización Mundial de la Salud. Preguntas frecuentes: Vacunas contra la COVID-19. Washington D.C.: OPS-OMS; 2023. https://bit.ly/3KppPpX
(7) World Health Organization. Weekly operational update on Covid-19. Geneva: WHO; 2021. https://bit.ly/3yIPHus
(8) Organización Panamericana de la Salud, Organización Mundial de la Salud. Novel coronavirus 2019. Washington D.C.: OPS-OMS; 2021. https://bit.ly/4bDEz0r
(9) Gobierno de México. Política nacional rectora de vacunación contra el virus SARS-CoV-2 para la prevención de la COVID-19 en México. México: Gobierno de México. 2021. https://bit.ly/45j7SmJ
(10) Soares P, Rocha JV, Moniz M, Gama A, Almeida-Laires P, Pedro AR, et al. Factors associated with COVID-19 vaccine hesitancy. Vaccines. 2021; 9(3): 300. https://doi.org/10.3390/vaccines9030300
(11) Murdaugh CL, Parsons MA, Pender NJ. Health promotion in nursing practice. 8th ed. EE.UU: Pearson; 2019. https://bit.ly/3VHwGBz
(12) Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: A web-based national survey. J Multidiscip Healthc. 2020; 13: 1657-63. https://doi.org/10.2147/JMDH.S276771
(13) Machida M, Nakamura I, Kojima T, Saito R, Nakaya T, Hanibuchi T, et al. Acceptance of a COVID-19 vaccine in Japan during the COVID-19 pandemic. Vaccines. 2021; 9(3): 210. https://doi.org/10.3390/vaccines9030210
(14) Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020; 26: 100495. https://doi.org/10.1016/j.eclinm.2020.100495
(15) Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Acceptance of a COVID-19 vaccine in Southeast Asia: A cross-sectional study in Indonesia. Front Public Heal. 2020; 8: 381. https://doi.org/10.3389/fpubh.2020.00381
(16) Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 2020; 38(42): 6500-7. https://doi.org/10.1016/j.vaccine.2020.08.043
(17) Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors. Prev Med. 2021; 150: 106694. http://dx.doi.org/10.1016/j.ypmed.2021.106694
(18) Secretaría de Gobernación. Decreto por el que se reforman, adicionan y derogan diversas disposiciones del Reglamento de la Ley General de Salud en Materia de Investigación para la Salud. México: DOF; 2014. https://bit.ly/3X3v46a
(19) Asociación Médica Mundial. Declaración de Helsinki de la AMM – Principios éticos para las investigaciones médicas en seres humanos. Francia: AMM; 2024. https://bit.ly/3Rx1N03
(20) Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020; 38(45): 7002-6. https://doi.org/10.1016/j.vaccine.2020.09.041
(21) Alqudeimat Y, Alenezi D, AlHajri B, Alfouzan H, Almokhaizeem Z, Altamimi S, et al. Acceptance of a COVID-19 vaccine and its related determinants among the general adult population in Kuwait. Med Princ Pract. 2021; 30(3): 262-71. http://dx.doi.org/10.1159/000514636
(22) Boche B, Kebede O, Damessa M, Gudeta T, Wakjira D. Health professionals’ COVID-19 vaccine acceptance and associated factors in tertiary hospitals of South-West Ethiopia: A multi-center cross-sectional study. Inquiry. 2022; 59. http://dx.doi.org/10.1177/00469580221083181
(23) Mascarenhas AK, Lucia VC, Kelekar A, Afonso NM. Dental students’ attitudes and hesitancy toward COVID-19 vaccine. J Dent Educ. 2021; 85(9): 1504-10. https://doi.org/10.1002/jdd.12632
(24) Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: The next challenge in the fight against COVID-19. Eur J Epidemiol. 2020; 35: 775-9. https://doi.org/10.1007/s10654-020-00671-y
(25) Wang K, Zuo P, Liu Y, Zhang M, Zhao X, Xie S, et al. Clinical and laboratory predictors of in-hospital mortality in patients with coronavirus disease-2019: A cohort study in Wuhan, China. Clin. Infect. Dis. 2020; 71(16): 2079-88. https://doi.org/10.1093/cid/ciaa538
(26) Dorión M, Ticona JPA, Fofona MO, Lind ML, Nery-Jr N, Victoriano R, et al. Social determinants of adult COVID-19 vaccine acceptance and uptake in a Brazilian urban informal community: A longitudinal time-to-event study. medRxiv. 2023; 1-27. https://doi.org/10.1101/2023.11.28.23298927
(27) Milligan MA, Hoyt DL, Gold AK, Hiserodt M, Otto MW. COVID-19 vaccine acceptance: Influential roles of political party and religiosity. Psychol Health Med. 2022; 27(9): 1907-17. https://doi.org/10.1080/13548506.2021.1969026
(28) Wang K, Wong ELY, Ho KF, Cheung AWL, Chan EYY, Yeoh EK, et al. Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey. Vaccine. 2020; 38(45): 7049–56. https://doi.org/10.1016/j.vaccine.2020.09.021
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Enfermería Universitaria by Universidad Nacional Autónoma de México it is distributed under the License Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International
Accepted and published articles become open-access under the terms of the Creative Commons CC BY-NC-ND 4.0 license, which authorizes the reproduction and sharing without commercial purposes, provided the corresponding acknowledgments to their authors. Authors are allowed to manage a self-archive copy of the article’s published version so that they can open-access it in their personal or institutional web pages, and/or any other broad-diffusion space.
